Year: 2023
Type: dissertation
Abstract: To understand organism function and disease and to target perturbed processes for therapy, comprehensive knowledge of the underlying cell signaling networks is required. However, mapping the interplay of the vast number of biomolecules involved in these networks remains challenging. As a result, efforts have focused on identifying the structural elements within biomolecules that facilitate signal transmission. Receptor tyrosine kinases (RTKs) regulate the function of several important organs and are most recognized as oncogenes in cancer. Research into the structural determinants of RTKs that govern their signaling has led to clinically approved therapies. However, some structural regions of these kinases remain poorly understood. In this thesis, the diversity of cell signaling arising from variation in an overlooked region in RTKs known as the extracellular juxtamembrane region was explored. A sequence motif that controls the cell surface location and the signaling of RTKs was identified, presenting a potential novel way to target RTKs for therapy. The cell signaling pathways that regulate myocardial growth could be putatively re-activated to treat heart failure or inhibited to treat pathological hypertrophy. Additionally, these pathways may hold the key to regenerating the myocardium post-injury. A pathway promoting myocardial growth involving STAT5b and the RTK ErbB4 was uncovered in this thesis. VEGFB, traditionally associated with endothelial cells, was additionally observed to elicit myocardial growth through paracrine signaling involving ErbB RTKs. Activation of ErbB4 pathways in the heart with NRG-1 has improved the cardiac function of heart failure patients implying that the discoveries made in this thesis may aid in heart failure therapy development. Finally, recent developments in omics technologies have facilitated the detection and quantification of the different layers of cell signaling networks. Consequently, a growing need for computational analyses capable of reverse-engineering cell signaling pathways from multi-omics data has emerged. In this thesis, a new computational approach specifically designed to discover cell signaling pathways from multi-omics data without the use of prior information was developed. These types of de novo methods remain essential for uncovering new cell signaling connections, which, in turn, can unveil potential new drug targets to treat disease.
Source: UTUPub (University of Turku)
Author: Vaparanta, Katri
Institution: University of Turku
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Turun Yliopisto, Åbo Akademi
OpenAlex ID: W7048716137
